IL17A and neoplasm: Our data revealed that rs8193036 T-allele carriers were associated with significantly more-advanced stages (III + IV) among LUAD patients, suggesting that IL-17A rs8193036 SNPs promote tumor progression probably via upregulation of IL-17A expression.